These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 12853838)

  • 41. Different combinations of genetic/epigenetic alterations inactivate the p53 and pRb pathways in invasive human bladder cancers.
    Sarkar S; Jülicher KP; Burger MS; Della Valle V; Larsen CJ; Yeager TR; Grossman TB; Nickells RW; Protzel C; Jarrard DF; Reznikoff CA
    Cancer Res; 2000 Jul; 60(14):3862-71. PubMed ID: 10919661
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pathogenetic and biologic significance of TP14ARF alterations in nonsmall cell lung carcinoma.
    Park MJ; Shimizu K; Nakano T; Park YB; Kohno T; Tani M; Yokota J
    Cancer Genet Cytogenet; 2003 Feb; 141(1):5-13. PubMed ID: 12581892
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Loss of CDKN2A and p14ARF expression occurs frequently in human nonmelanoma skin cancers.
    Pacifico A; Goldberg LH; Peris K; Chimenti S; Leone G; Ananthaswamy HN
    Br J Dermatol; 2008 Feb; 158(2):291-7. PubMed ID: 18070208
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Incidence of p14ARF gene deletion in high-grade adult and pediatric astrocytomas.
    Newcomb EW; Alonso M; Sung T; Miller DC
    Hum Pathol; 2000 Jan; 31(1):115-9. PubMed ID: 10665922
    [TBL] [Abstract][Full Text] [Related]  

  • 45. p16INK4A alterations are accompanied by aberrant protein immunostaining in endometrial carcinomas.
    Semczuk A; Boltze C; Marzec B; Szczygielska A; Roessner A; Schneider-Stock R
    J Cancer Res Clin Oncol; 2003 Oct; 129(10):589-96. PubMed ID: 12920579
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Alteration of the p14(ARF) gene and p53 status in human hepatocellular carcinomas.
    Ito T; Nishida N; Fukuda Y; Nishimura T; Komeda T; Nakao K
    J Gastroenterol; 2004; 39(4):355-61. PubMed ID: 15168247
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Aberrations of p16INK4A, p14ARF and p15INK4B genes in pediatric solid tumors.
    Obana K; Yang HW; Piao HY; Taki T; Hashizume K; Hanada R; Yamamoto K; Tanaka Y; Toyoda Y; Takita J; Tsuchida Y; Hayashi Y
    Int J Oncol; 2003 Oct; 23(4):1151-7. PubMed ID: 12963998
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mutation profile of the p53, fhit, p16INK4a/p19ARF and H-ras genes in Indian breast carcinomas.
    Kannan K; Krishnamurthy J; Feng J; Nakajima T; Tsuchida N; Shanmugam G
    Int J Oncol; 2000 Nov; 17(5):1031-5. PubMed ID: 11029509
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The mechanism of p16 gene inactivation in human bladder transitional cell carcinoma].
    Wu Y; Wu H; Ma T; Wu C
    Zhonghua Bing Li Xue Za Zhi; 1999 Feb; 28(1):39-41. PubMed ID: 11869511
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mechanisms of inactivation of the p16INK4a gene in leiomyosarcoma of soft tissue: decreased p16 expression correlates with promoter methylation and poor prognosis.
    Kawaguchi K; Oda Y; Saito T; Yamamoto H; Tamiya S; Takahira T; Miyajima K; Iwamoto Y; Tsuneyoshi M
    J Pathol; 2003 Nov; 201(3):487-95. PubMed ID: 14595762
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Deletions and loss of expression of p16INK4a and p21Waf1 genes are associated with aggressive variants of mantle cell lymphomas.
    Pinyol M; Hernandez L; Cazorla M; Balbín M; Jares P; Fernandez PL; Montserrat E; Cardesa A; Lopez-Otín C; Campo E
    Blood; 1997 Jan; 89(1):272-80. PubMed ID: 8978301
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Alterations of cyclin-dependent kinase 4 inhibitor (p16INK4A/MTS1) gene structure and expression in acute lymphoblastic leukemias.
    Delmer A; Tang R; Senamaud-Beaufort C; Paterlini P; Brechot C; Zittoun R
    Leukemia; 1995 Jul; 9(7):1240-5. PubMed ID: 7630199
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inactivation of the INK4A/ARF locus frequently coexists with TP53 mutations in non-small cell lung cancer.
    Sanchez-Cespedes M; Reed AL; Buta M; Wu L; Westra WH; Herman JG; Yang SC; Jen J; Sidransky D
    Oncogene; 1999 Oct; 18(43):5843-9. PubMed ID: 10557071
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Analysis of cell cycle regulators: p16INK4A, pRb, and CDK4 in low- and high-grade meningiomas.
    Tse JY; Ng HK; Lo KW; Chong EY; Lam PY; Ng EK; Poon WS; Huang DP
    Hum Pathol; 1998 Nov; 29(11):1200-7. PubMed ID: 9824096
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Coincidental alterations of p16INK4A/CDKN2 and other genes in human lung cancer cell lines.
    Fujishita T; Mizushima Y; Kashii T; Kobayashi M
    Anticancer Res; 1998; 18(3A):1537-42. PubMed ID: 9673367
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Homozygous deletion of the p16INK4a and the p15INK4b tumour suppressor genes in a subset of human sporadic cutaneous malignant melanoma.
    Wagner SN; Wagner C; Briedigkeit L; Goos M
    Br J Dermatol; 1998 Jan; 138(1):13-21. PubMed ID: 9536218
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Expression of p16INK4A and p14ARF in hematological malignancies.
    Taniguchi T; Chikatsu N; Takahashi S; Fujita A; Uchimaru K; Asano S; Fujita T; Motokura T
    Leukemia; 1999 Nov; 13(11):1760-9. PubMed ID: 10557050
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Genetic alterations of INK4alpha/ARF locus and p53 in human hepatocellular carcinoma.
    Peng CY; Chen TC; Hung SP; Chen MF; Yeh CT; Tsai SL; Chu CM; Liaw YF
    Anticancer Res; 2002; 22(2B):1265-71. PubMed ID: 12168936
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Promoter hypermethylation and quantitative expression analysis of CDKN2A (p14ARF and p16INK4a) gene in esophageal squamous cell carcinoma.
    Ito S; Ohga T; Saeki H; Watanabe M; Kakeji Y; Morita M; Yamada T; Maehara Y
    Anticancer Res; 2007; 27(5A):3345-53. PubMed ID: 17970080
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Early acquisition of homozygous deletions of p16/p19 during squamous cell carcinogenesis and genetic mosaicism in bladder cancer.
    Tsutsumi M; Tsai YC; Gonzalgo ML; Nichols PW; Jones PA
    Oncogene; 1998 Dec; 17(23):3021-7. PubMed ID: 9881704
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.